TCIM
AMED

TIAA CREF Investment Management’s Amedisys AMED Stock Holding History

TIAA CREF Investment Management’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$16M Buy
129,939
+19,357
+18% +$2.43M 0.01% 809
2018
Q4 		$12.9M Sell
110,582
-7,384
-6% -$870K 0.01% 832
2018
Q3 		$14.7M Sell
117,966
-7,378
-6% -$815K 0.01% 896
2018
Q2 		$10.7M Sell
125,344
-3,129
-2% -$230K 0.01% 1118
2018
Q1 		$7.75M Sell
128,473
-850
-0.7% -$48.4K 0.01% 1283
2017
Q4 		$6.82M Sell
129,323
-17,075
-12% -$900K ﹤0.01% 1406
2017
Q3 		$8.19M Buy
146,398
+18,263
+14% +$966K 0.01% 1276
2017
Q2 		$8.05M Sell
128,135
-7,105
-5% -$414K 0.01% 1275
2017
Q1 		$6.91M Sell
135,240
-26,518
-16% -$1.26M 0.01% 1375
2016
Q4 		$6.9M Sell
161,758
-25,794
-14% -$1.1M 0.01% 1386
2016
Q3 		$8.9K Sell
187,552
-12,493
-6% -$623K 0.01% 1199
2016
Q2 		$10.1M Sell
200,045
-24,680
-11% -$1.25M 0.01% 1053
2016
Q1 		$10.9M Sell
224,725
-203
-0.1% -$7.83K 0.01% 1014
2015
Q4 		$8.84M Buy
224,928
+15,943
+8% +$638K 0.01% 1137
2015
Q3 		$7.93M Buy
208,985
+45,118
+28% +$1.9M 0.01% 1194
2015
Q2 		$6.51M Sell
163,867
-19,405
-11% -$605K ﹤0.01% 1482
2015
Q1 		$4.91M Sell
183,272
-1,658
-0.9% -$46.8K ﹤0.01% 1644
2014
Q4 		$5.43M Sell
184,930
-8,449
-4% -$209K ﹤0.01% 1575
2014
Q3 		$3.9M Sell
193,379
-4,052
-2% -$78.2K ﹤0.01% 1793
2014
Q2 		$3.31M Sell
197,431
-13,320
-6% -$189K ﹤0.01% 1970
2014
Q1 		$3.14M Sell
210,751
-2,360
-1% -$36.3K ﹤0.01% 1957
2013
Q4 		$3.12M Sell
213,111
-2,740
-1% -$44.1K ﹤0.01% 1963
2013
Q3 		$3.72M Sell
215,851
-684
-0.3% -$10.1K ﹤0.01% 1803
2013
Q2 		$2.52M Buy
+216,535
New +$2.48M ﹤0.01% 2020

Other funds holding AMED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

TIAA CREF Investment Management's AMED Position: Q1 2019 in Review

TIAA CREF Investment Management increased its Amedisys (AMED) stake by 18% in Q1 2019, buying an estimated $2.43M and bringing the position to 129,939 shares worth $16M. The position accounts for 0.01% of the portfolio, ranked #809.

TIAA CREF Investment Management first reported a position in AMED in Q2 2013 and has held it in 24 quarters since. 317 funds tracked by Wall St. Rank hold AMED as of Q1 2019.

  • TIAA CREF Investment Management held 129,939 shares of Amedisys worth $16M as of Q1 2019.
  • TIAA CREF Investment Management bought 19,357 Amedisys shares in Q1 2019, an estimated $2.43M.
  • Amedisys made up 0.01% of TIAA CREF Investment Management's portfolio in Q1 2019, its #809 holding.
  • TIAA CREF Investment Management first reported a position in Amedisys in Q2 2013 and has held it in 24 quarters since.
  • 317 funds tracked by Wall St. Rank held Amedisys as of Q1 2019.

Based on TIAA CREF Investment Management's 13F filing for Q1 2019, filed 14 May 2019.